Specifically, MFN2 mutations are linked to Charcot-Marie-Tooth disease (CMT) and OPA1 mutations are associated with autosomal dominant optic atrophy (ADOA) [86–88]. Here, OPA1 is linked to autosomal dominant optic atrophy.